Zur Kurzanzeige

dc.contributor.authorMartín Sánchez, Carlos 
dc.contributor.authorBarbero Iglesias, Fausto José 
dc.contributor.authorAmor Esteban, Victor
dc.contributor.authorMartín Sánchez, Marta
dc.contributor.authorMartín Nogueras, Ana María 
dc.date.accessioned2025-07-15T06:56:41Z
dc.date.available2025-07-15T06:56:41Z
dc.date.issued2025-06-20
dc.identifier.citationMartin-Sanchez C, Barbero-Iglesias FJ, Amor-Esteban V, Martin-Sanchez M, Martin-Nogueras AM. Inspiratory Muscle Training in Adults With Cerebral Palsy: Long Term Effects: A Double-Blind Randomized, Controlled Trial. Res Nurs Health. 2025 Jun 20. doi: 10.1002/nur.70000. Epub ahead of print. PMID: 40539466.es_ES
dc.identifier.issn0160-6891
dc.identifier.urihttp://hdl.handle.net/10366/166455
dc.descriptionFinanciación de acceso abierto proporcionada por los Fondos Europeos FEDER y la Junta de Castilla y León en el marco de la Estrategia de Investigación e Innovación para la Especialización Inteligente (RIS3) de Castilla y León 2021-2027es_ES
dc.description.abstract[EN] Respiratory disease is one of the main causes of morbidity and mortality in adults with cerebral palsy (CP). The main objective of the study was to investigate the maintenance over time of improvements in respiratory parameters achieved with inspiratory muscle training (IMT). This was a randomized, controlled, double-blind trial and with allocation concealment performed on 27 institutionalized CP patients randomly distributed in two groups: "high intensity training group" (HIT) trained with a load of 40% of the maximum inspiratory pressure (MIP) and "low intensity training group" (LIT) with 20%. Respiratory strength and pulmonary function were evaluated throughout the study. Four weeks after IMT most improvements persisted. Twelve weeks after IMT, only HIT maintained significant improvements (p = 0.001) in MIP; 24 weeks after IMT, in the HIT group, MIP was 10% higher than the initial results and pulmonary function parameters were 1% lower. In the LIT group, respiratory strength and pulmonary function were lower than at baseline. Improvements achieved with IMT are reduced over time once the treatment ends. During the first 4 weeks posttreatment, the benefits persist but from the 12th week there was a progressive loss of the improvement reaching a total loss at 24 weeks. To be most effective, a higher MIP load is suggested for respiratory treatment, which must be maintained over time and interruptions should not be longer than 4 weeks. Clinical trial registration. The study was registered in the clinical trials database of the United States National Library of Medicine (www.clinicaltrials.gov) with the number of registration NCT04915170.en
dc.language.isoenges_ES
dc.publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/nur.70000es_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectRM‐ANOVAen
dc.subjectagingen
dc.subjectcerebral palsyen
dc.subjectmuscle strengthen
dc.subjectrehabilitationen
dc.subjectrespiratory exercisesen
dc.subject.meshMuscle Strength *
dc.subject.meshCerebral Palsy *
dc.subject.meshAging *
dc.subject.meshRehabilitation *
dc.titleInspiratory muscle training in adults with cerebral palsy: long term effects: a double-blind randomized, controlled trialen
dc.typeinfo:eu-repo/semantics/articleen
dc.relation.publishversionhttps://doi.org/10.1002/NUR.70000es_ES
dc.identifier.doi10.1002/nur.70000
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid40539466
dc.identifier.essn1098-240X
dc.journal.titleReserach in Nursing & Healthes_ES
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersionen
dc.subject.decsfuerza muscular *
dc.subject.decsparálisis cerebral *
dc.subject.decsenvejecimiento *
dc.subject.decsrehabilitación *
dc.description.projectProfessional College of Physiotherapists of Castilla y Leones_ES


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional